Catapres (Boehringer Ingelheim Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Catapres drug offered from Boehringer Ingelheim Pharmaceuticals Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | clonidine |
| SUBSTANCE NAME: | CLONIDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
| ROUTE: | TRANSDERMAL |
| DOSAGE FORM: | PATCH, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1985-10-01 |
| END MARKETING DATE: | 0000-00-00 |
Catapres HUMAN PRESCRIPTION DRUG Details:
| Item Description | Catapres from Boehringer Ingelheim Pharmaceuticals Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.1(mg/24h) |
| START MARKETING DATE: | 1985-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0031_5b22f8cb-2f48-4f70-b996-f9ab65e758c4 |
| PRODUCT NDC: | 0597-0031 |
| APPLICATION NUMBER: | NDA018891 |
Other CLONIDINE Pharmaceutical Manufacturers / Labelers:
